Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
interleukin 2 | 0.336 | 0.885 | 0.48 |
|
phenotype | 0.330 | None | 1.000 | 3 | 0 | 1992 | 2019 | ||||||||
|
colony stimulating factor 2 | 0.330 | 0.962 | 0.83 |
|
phenotype | 0.310 | None | 1.000 | 1 | 0 | 1999 | 2004 | ||||||||
|
ABL proto-oncogene 1, non-receptor tyrosine kinase | 0.432 | 0.923 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 76 | 0 | 1992 | 2019 | ||||||||
|
T cell receptor beta variable 20/OR9-2 (non-functional) | 0.403 | 0.923 |
|
phenotype | 0.100 | None | 0.954 | 65 | 0 | 1991 | 2020 | |||||||||
|
nucleophosmin 1 | 0.464 | 0.846 | 1.00 |
|
phenotype | 0.100 | None | 0.978 | 46 | 0 | 2005 | 2020 | ||||||||
|
RUNX family transcription factor 1 | 0.425 | 0.808 | 0.65 |
|
phenotype | 0.100 | None | 0.953 | 43 | 0 | 1993 | 2019 | ||||||||
|
immunoglobulin heavy locus | 0.473 | 0.654 |
|
phenotype | 0.100 | None | 0.949 | 39 | 0 | 1993 | 2019 | |||||||||
|
fms related receptor tyrosine kinase 3 | 0.462 | 0.654 | 0.61 |
|
phenotype | 0.100 | None | 0.946 | 37 | 0 | 2001 | 2020 | ||||||||
|
BCR activator of RhoGEF and GTPase | 0.431 | 0.885 | 0.99 |
|
phenotype | 0.100 | None | 1.000 | 35 | 0 | 1990 | 2020 | ||||||||
|
RUNX1 partner transcriptional co-repressor 1 | 0.530 | 0.808 | 0.98 |
|
phenotype | 0.100 | None | 0.966 | 29 | 0 | 1993 | 2019 | ||||||||
|
WT1 transcription factor | 0.422 | 0.808 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 28 | 0 | 1994 | 2018 | ||||||||
|
ETS variant transcription factor 6 | 0.477 | 0.731 | 0.97 |
|
phenotype | 0.100 | None | 0.962 | 26 | 0 | 1996 | 2019 | ||||||||
|
lysine methyltransferase 2A | 0.410 | 0.885 | 1.00 |
|
phenotype | 0.100 | None | 0.962 | 25 | 0 | 1996 | 2018 | ||||||||
|
BCL2 apoptosis regulator | 0.291 | 0.885 | 0.56 |
|
phenotype | 0.100 | None | 0.952 | 20 | 0 | 1997 | 2020 | ||||||||
|
promyelocytic leukemia | 0.477 | 0.846 | 0.21 |
|
phenotype | 0.100 | None | 1.000 | 16 | 0 | 1992 | 2012 | ||||||||
|
PML-RARA regulated adaptor molecule 1 | 0.700 | 0.462 | 3.0E-04 |
|
phenotype | 0.100 | None | 1.000 | 15 | 0 | 1993 | 2002 | ||||||||
|
CD19 molecule | 0.430 | 0.885 | 0.90 |
|
phenotype | 0.100 | None | 1.000 | 15 | 0 | 2000 | 2019 | ||||||||
|
myosin heavy chain 11 | 0.528 | 0.731 | 0.77 |
|
phenotype | 0.100 | None | 1.000 | 13 | 0 | 1995 | 2017 | ||||||||
|
CD34 molecule | 0.368 | 0.808 | 5.0E-06 |
|
phenotype | 0.100 | None | 1.000 | 12 | 0 | 1995 | 2019 | ||||||||
|
IKAROS family zinc finger 1 | 0.533 | 0.769 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 12 | 0 | 2011 | 2019 | ||||||||
|
Cerebellar degeneration-related autoantigen-3 | 0.472 | 0.808 |
|
phenotype | 0.100 | None | 1.000 | 11 | 0 | 1995 | 2019 | |||||||||
|
secretin | 0.484 | 0.846 | 1.4E-07 |
|
phenotype | 0.100 | None | 1.000 | 11 | 0 | 2008 | 2019 | ||||||||
|
T cell receptor gamma locus | 0.631 | 0.538 |
|
phenotype | 0.100 | None | 0.900 | 10 | 0 | 1998 | 2012 | |||||||||
|
preferentially expressed antigen in melanoma | 0.531 | 0.577 | 2.4E-07 |
|
phenotype | 0.100 | None | 0.900 | 10 | 0 | 2001 | 2016 | ||||||||
|
T cell receptor gamma constant 1 | 0.663 | 0.385 |
|
phenotype | 0.090 | None | 0.889 | 9 | 0 | 1998 | 2012 |